About
Laser-mediated Tumor Ablation
Areas of Focus
Categories
Surgical DeviceSouthwestern U.S.
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
117
By Phase
NA: 4
By Status
COMPLETED: 2UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04240639Lead Sponsor
An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
NAUnknown
60 participants
Started: Jan 30, 2020 · Completed: Jun 30, 2023
NCT02680535Lead Sponsor
MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
NACompleted
45 participants
Started: Feb 29, 2016 · Completed: Oct 31, 2020
NCT01679470Lead Sponsor
Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors
NATerminated
1 participants
Started: Oct 31, 2012 · Completed: Jun 30, 2014
NCT00848042Lead Sponsor
Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck
NACompleted
11 participants
Started: Apr 30, 2008 · Completed: Aug 31, 2014
Locations (1)
Headquarters
Houston, TX, United States
Map
Loading map...